热门资讯> 正文
2024-08-27 02:40
02:40 PM EDT, 08/26/2024 (MT Newswires) -- MoonLake Immunotherapeutics (MLTX) shares fell 2.1% in recent Monday trading after Wolfe Research downgraded the company's stock to peer perform from outperform.
Trading volume stood at about 68,000 shares against a daily average of more than 344,000.
Price: 48.75, Change: -1.02, Percent Change: -2.05